title: Influence of continuous erythropoietin receptor activator on markers of cardiovascular risk in chronic kidney disease patients.
authors.forename: Annalisa
authors.initials: A
authors.lastname: Noce
authors.forename: Mariarita
authors.initials: M
authors.lastname: Dessì
authors.forename: Olga
authors.initials: O
authors.lastname: Durante
authors.forename: Simone
authors.initials: S
authors.lastname: Manca di Villahermosa
authors.forename: Maria Paola
authors.initials: MP
authors.lastname: Canale
authors.forename: Nicola
authors.initials: N
authors.lastname: Di Daniele
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000097:blood* / Q000188:drug therapy*; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D010865:Pilot Projects; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D051436:Renal Insufficiency, Chronic / Q000097:blood* / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D015415:Biomarkers; C508420:continuous erythropoietin receptor activator; D004921:Erythropoietin; D011092:Polyethylene Glycols